• Sonuç bulunamadı

Viral Hepatitis Journal VİRAL HEPATİT DERGİSİ

N/A
N/A
Protected

Academic year: 2021

Share "Viral Hepatitis Journal VİRAL HEPATİT DERGİSİ"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Letter from the Editor,

We are so glad that the 3rd issue of our journal in English is to be published. It is so pleasing that the number and the quality of the manuscripts submitted to our journal increases. We can never thank our editors enough for their evaluations in a short duration of time.

This issue includes different epidemiological and clinic researches and case reports on viral hepatitis. The research addresses the etiological distribution of cases with hyperbilirubinemia accompanying high ALT levels would attract your attention.

Current researches on HBV and HCV prevalence are included also in this issue.

Manuscripts addressing distribution of HCV genotypes in East Anatolian Region and cases waiting for new HCV therapies are among substantive manuscripts of this issue.

Moreover, there is a research comparing two different methods used in the detecting HBcAg.

I wish you a happy new year.

Hope to see you in our future issues.

Fehmi Tabak, MD, Prof.

Editor

EDITORIAL

A-V

VIRAL HEPATITIS SOCIETY

Viral Hepatitis Journal

VİRAL HEPATİT DERGİSİ

Referanslar

Benzer Belgeler

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors,

Objectives: The aim of this study was to determine the frequency of blood-borne infections [hepatitis B virus (HBV), HCV, and human immunodeficiency virus (HIV)] and the

Objectives: The study aimed to investigate the seroprevalence of hepatitis B surface antigen (HBsAg) and hepatitis C virus (anti- HCV) in human immunodeficiency virus (HIV)

Distribution of hepatitis C virus genotypes among patients with chronic hepatitis C infection in Akdeniz University Hospital, Antalya, Turkey: A five-year evaluation. Kuscu F,

In this study, we retrospectively evaluated the results of test performed in the Central Laboratory of İstanbul Northern Anatolian Association of Public Hospitals to determine the

Ülkü ORAL ZEYTİNLİ, Fatma MUHTEREM YÜCEL, Şölen DALDABAN DİNÇER, Özgür YANILMAZ, Sebahat AKSARAY, Kamil ÖZDİL. Association of Public Hospitals Northern Anatolian Region

More recently, together with a combination of sofosbuvir 400 mg and ledipasvir 90 mg, the dual regimen of sofosbuvir 400 mg and daclatasvir 60 mg has raised up as a more

The aim of the present study was to investigate the seropositivity rates for HBV, anti-HBs, anti-HBc IgG, anti-HCV, and anti-HIV 1-2 among healthcare professionals at the